Log In
Print
BCIQ
Print
Print this Print this
 

FS102

  Manage Alerts
Collapse Summary General Information
Company F-star Alpha Ltd.
DescriptionAntibody fragment targeting Epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu)
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Bristol-Myers Squibb Co.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today